Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Apeiron Biologics AG
DescriptionAutologous peripheral blood mononuclear cells (PBMCs) silenced ex vivo for the casitas B cell lymphoma-b (Cbl-b) gene using small interfering RNA (siRNA) and re-administered to the patient
Molecular Target Casitas B cell lymphoma-b (Cbl-b)
Mechanism of ActionImmune modulation
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat metastatic or inoperable solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today